DXR$9.002.17%-0.20
Daxor Corp (DXR)
Date: 2026-11-02 16:00O: 9.19H: 9.19L: 8.90C: 9.00Vol: 3.703k
Daxor Corp stock is traded at $9.00, with a volume of 3,703. It is down -2.17% in the last 24 hours and down -15.25% over the past month. Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
Previous Close:
$9.20
Open:
$9.19
24h Volume:
3,703
Relative Volume:
0.31
Market Cap:
$52.54M
Revenue:
$503.40K
Net Income/Loss:
$9.17M
P/E Ratio:
4.97
EPS:
$1.81
Net Cash Flow:
-$604.40K
1W Performance:
+1.24%
1M Performance:
-15.25%
6M Performance:
-13.79%
1Y Performance:
-31.25%
1-Day Range:
$0.00$0.00
1-Week Range:
$8.40$9.20
52-Week Range:
$8.40$14.76
Daxor Corp Stock (DXR) Company Profile
Name
Daxor CorpSector
HealthcareIndustry
Medical Instruments & SuppliesPhone
(212) 244-0555Address
350 FIFTH AVENUE, NEW YORK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Daxor Corp Stock (DXR) Upgrades & Downgrades
Daxor Corp Stock (DXR) Financials Data
Daxor Corp Stock (DXR) Insider Trading
- Feldschuh Michael RichardApr 08 '26Chief Executive Officer
- Transaction
- Buy
- Cost
- $9.07
- #Shares
- 1,000
- Value ($)
- 9,070
- #Shares Total
- 213,694
- Michel Robert JMar 31 '26Chief Financial Officer
- Transaction
- Buy
- Cost
- $9.90
- #Shares
- 1,000
- Value ($)
- 9,900
- #Shares Total
- 21,050
